Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors

Throughout its known history, the gram-negative bacterium Chlamydia pneumoniae has remained a challenging target for antibacterial chemotherapy and drug discovery. Owing to its well-known propensity for persistence and recent reports on antimicrobial resistence within closely related species, new ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanski, Leena, Vuorela, Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192526/
https://www.ncbi.nlm.nih.gov/pubmed/27916800
http://dx.doi.org/10.3390/microorganisms4040043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192526/
https://www.ncbi.nlm.nih.gov/pubmed/27916800
http://dx.doi.org/10.3390/microorganisms4040043

Ejemplares similares